Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action

Immunotherapy, Ahead of Print.

Source: Immunotherapy - January 30, 2019 Category: Allergy & Immunology Authors: Ni Zhang Jingyao Tu Xue Wang Qian Chu Source Type: research